Literature DB >> 9439810

Induction of LIF-mRNA by TGF-beta 1 in Schwann cells.

I Matsuoka1, A Nakane, K Kurihara.   

Abstract

Schwann cell is a cell type that forms myelin sheath and provides trophic supports for neuronal cells by producing neurotrophic factors such as neurotrophins and neurokines in both normal and traumatic situations. It was recently reported that after lesion of sciatic nerve, mRNA for cholinergic differentiation factor (CDF)/leukemia inhibitory factor (LIF) is induced in nonneuronal cells in the nerve. However, the source of LIF-mRNA and the mechanism of LIF-mRNA regulation have remained largely unknown. In the present study, we searched for factors regulating the LIF-mRNA expression in cultured Schwann cells isolated from newborn rat sciatic nerve. Among various growth factors and cytokines tested, TGF beta-1 exerted the most prominent effect on the induction of LIF-mRNA in the cultured Schwann cells. The effect of TGF-beta 1 on the increase of LIF-mRNA levels was suppressed by either staurosporine or H-7 suggesting the role of PKC or PKC-like protein kinase activity in the induction of LIF-mRNA. The induction of LIF mRNA by TGF-beta 1 was suppressed in the co-culture of the Schwann cells with embryonic rat DRG neurons. The addition of ascorbic acid, which is known to promote myelination in this co-culture system, further suppressed the TGF-beta 1 induction of LIF-mRNA. These results suggest that Schwann cells respond to TGF-beta 1 in a lesion situation to produce LIF, which supports neuronal survival and regeneration. The re-establishment of neuron-Schwann cell interaction would in turn suppress the LIF production to terminate its action during the lesion situation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439810     DOI: 10.1016/s0006-8993(97)01015-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

2.  Inhibition of astrocyte FAK-JNK signaling promotes subventricular zone neurogenesis through CNTF.

Authors:  Cuihong Jia; Matthew P Keasey; Chiharu Lovins; Theo Hagg
Journal:  Glia       Date:  2018-11       Impact factor: 7.452

Review 3.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

4.  Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling.

Authors:  Matthew P Keasey; Cuihong Jia; Lylyan F Pimentel; Richard R Sante; Chiharu Lovins; Theo Hagg
Journal:  J Cell Sci       Date:  2018-02-02       Impact factor: 5.285

5.  Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.

Authors:  Kuniaki Ota; Patrick Quint; Megan M Weivoda; Ming Ruan; Larry Pederson; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Bone       Date:  2013-07-25       Impact factor: 4.398

6.  gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.

Authors:  Richard E Zigmond
Journal:  Front Mol Neurosci       Date:  2012-01-20       Impact factor: 5.639

7.  The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.

Authors:  Laure Humbert; Mostafa Ghozlan; Lucie Canaff; Jun Tian; Jean-Jacques Lebrun
Journal:  BMC Cancer       Date:  2015-03-29       Impact factor: 4.430

8.  Identification of adequate vehicles to carry nerve regeneration inducers using tubulisation.

Authors:  Adriana Helena do Nascimento-Elias; Bruno César Fresnesdas; Maria Cristina Lopes Schiavoni; Natália Fernanda Gaspar de Almeida; Ana Paula Santos; Jean de Oliveira Ramos; Wilson Marques Junior; Amilton Antunes Barreira
Journal:  BMC Neurosci       Date:  2012-08-14       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.